Back to Search Start Over

Sex Disparities in Outcomes Following Major Liver Surgery: New Powers of Estrogen?

Authors :
Birrer DL
Linecker M
López-López V
Brusadin R
Navarro-Barrios Á
Reese T
Arbabzadah S
Balci D
Malago M
Machado MA
Ardiles V
Soubrane O
Hernandez-Alejandro R
de Santibañes E
Oldhafer KJ
Popescu I
Humar B
Clavien PA
Robles-Campos R
Source :
Annals of surgery [Ann Surg] 2022 Nov 01; Vol. 276 (5), pp. 875-881. Date of Electronic Publication: 2022 Jul 27.
Publication Year :
2022

Abstract

Aim: To explore potential sex differences in outcomes and regenerative parameters post major hepatectomies.<br />Background: Although controversial, sex differences in liver regeneration have been reported for animals. Whether sex disparity exists in human liver regeneration is unknown.<br />Methods: Data from consecutive hepatectomy patients (55 females, 67 males) and from the international ALPPS (Associating-Liver-Partition-and-Portal-vein-ligation-for-Staged-hepatectomy, a two stage hepatectomy) registry (449 females, 729 males) were analyzed. Endpoints were severe morbidity (≥3b Clavien-Dindo grades), Model for End-stage Liver Disease (MELD) scores, and ALPPS interstage intervals. For validation and mechanistic insight, female-male ALPSS mouse models were established. t , χ 2 , or Mann-Whitney tests were used for comparisons. Univariate/multivariate analyses were performed with sensitivity inclusion.<br />Results: Following major hepatectomy (Hx), males had more severe complications ( P =0.03) and higher liver dysfunction (MELD) P =0.0001) than females. Multivariate analysis established male sex as a predictor of complications after ALPPS stage 1 (odds ratio=1.78; 95% confidence interval: 1.126-2.89; P =0.01), and of enhanced liver dysfunction after stage 2 (odds ratio=1.93; 95% confidence interval: 1.01-3.69; P =0.045). Female patients displayed shorter interstage intervals (<2 weeks, 64% females versus 56% males, P =0.01), however, not in postmenopausal subgroups. In mice, females regenerated faster than males after ALPPS stage 1, an effect that was lost upon estrogen antagonism.<br />Conclusions: Poorer outcomes after major surgery in males and shorter ALPPS interstage intervals in females not necessarily suggest a superior regenerative capacity of female liver. The loss of interstage advantages in postmenopausal women and the mouse experiments point to estrogen as the driver behind these sex disparities. Estrogen's benefits call for an assessment in postmenopausal women, and perhaps men, undergoing major liver surgery.<br />Competing Interests: The authors report no conflicts of interest.<br /> (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1528-1140
Volume :
276
Issue :
5
Database :
MEDLINE
Journal :
Annals of surgery
Publication Type :
Academic Journal
Accession number :
35894447
Full Text :
https://doi.org/10.1097/SLA.0000000000005635